Herpes simplex virus infection, Acyclovir and IVIG treatment all independently cause gut dysbiosis.

Herpes simplex virus 1 (HSV) is a ubiquitous human virus resident in a majority of the global population as a latent infection. Acyclovir (ACV), is the standard of care drug used to treat primary and recurrent infections, supplemented in some patients with intravenous immunoglobulin (IVIG) treatment...

Full description

Bibliographic Details
Main Authors: Chandran Ramakrishna, Stacee Mendonca, Paul M Ruegger, Jane Hannah Kim, James Borneman, Edouard M Cantin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0237189
_version_ 1819113093824774144
author Chandran Ramakrishna
Stacee Mendonca
Paul M Ruegger
Jane Hannah Kim
James Borneman
Edouard M Cantin
author_facet Chandran Ramakrishna
Stacee Mendonca
Paul M Ruegger
Jane Hannah Kim
James Borneman
Edouard M Cantin
author_sort Chandran Ramakrishna
collection DOAJ
description Herpes simplex virus 1 (HSV) is a ubiquitous human virus resident in a majority of the global population as a latent infection. Acyclovir (ACV), is the standard of care drug used to treat primary and recurrent infections, supplemented in some patients with intravenous immunoglobulin (IVIG) treatment to suppress infection and deleterious inflammatory responses. As many diverse medications have recently been shown to change composition of the gut microbiome, we used Illumina 16S rRNA gene sequencing to determine the effects of ACV and IVIG on the gut bacterial community. We found that HSV, ACV and IVIG can all independently disrupt the gut bacterial community in a sex biased manner when given to uninfected C57BL/6 mice. Treatment of HSV infected mice with ACV or IVIG alone or together revealed complex interactions between these drugs and infection that caused pronounced sex biased dysbiosis. ACV reduced Bacteroidetes levels in male but not female mice, while levels of the Anti-inflammatory Clostridia (AIC) were reduced in female but not male mice, which is significant as these taxa are associated with protection against the development of graft versus host disease (GVHD) in hematopoietic stem cell transplant (HSCT) patients. Gut barrier dysfunction is associated with GVHD in HSCT patients and ACV also decreased Akkermansia muciniphila, which is important for maintaining gut barrier functionality. Cumulatively, our data suggest that long-term prophylactic ACV treatment of HSCT patients may contribute to GVHD and also potentially impact immune reconstitution. These data have important implications for other clinical settings, including HSV eye disease and genital infections, where ACV is given long-term.
first_indexed 2024-12-22T04:23:56Z
format Article
id doaj.art-a49303d7b92d46cc9bffef0e81cd9927
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-22T04:23:56Z
publishDate 2020-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-a49303d7b92d46cc9bffef0e81cd99272022-12-21T18:39:13ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-01158e023718910.1371/journal.pone.0237189Herpes simplex virus infection, Acyclovir and IVIG treatment all independently cause gut dysbiosis.Chandran RamakrishnaStacee MendoncaPaul M RueggerJane Hannah KimJames BornemanEdouard M CantinHerpes simplex virus 1 (HSV) is a ubiquitous human virus resident in a majority of the global population as a latent infection. Acyclovir (ACV), is the standard of care drug used to treat primary and recurrent infections, supplemented in some patients with intravenous immunoglobulin (IVIG) treatment to suppress infection and deleterious inflammatory responses. As many diverse medications have recently been shown to change composition of the gut microbiome, we used Illumina 16S rRNA gene sequencing to determine the effects of ACV and IVIG on the gut bacterial community. We found that HSV, ACV and IVIG can all independently disrupt the gut bacterial community in a sex biased manner when given to uninfected C57BL/6 mice. Treatment of HSV infected mice with ACV or IVIG alone or together revealed complex interactions between these drugs and infection that caused pronounced sex biased dysbiosis. ACV reduced Bacteroidetes levels in male but not female mice, while levels of the Anti-inflammatory Clostridia (AIC) were reduced in female but not male mice, which is significant as these taxa are associated with protection against the development of graft versus host disease (GVHD) in hematopoietic stem cell transplant (HSCT) patients. Gut barrier dysfunction is associated with GVHD in HSCT patients and ACV also decreased Akkermansia muciniphila, which is important for maintaining gut barrier functionality. Cumulatively, our data suggest that long-term prophylactic ACV treatment of HSCT patients may contribute to GVHD and also potentially impact immune reconstitution. These data have important implications for other clinical settings, including HSV eye disease and genital infections, where ACV is given long-term.https://doi.org/10.1371/journal.pone.0237189
spellingShingle Chandran Ramakrishna
Stacee Mendonca
Paul M Ruegger
Jane Hannah Kim
James Borneman
Edouard M Cantin
Herpes simplex virus infection, Acyclovir and IVIG treatment all independently cause gut dysbiosis.
PLoS ONE
title Herpes simplex virus infection, Acyclovir and IVIG treatment all independently cause gut dysbiosis.
title_full Herpes simplex virus infection, Acyclovir and IVIG treatment all independently cause gut dysbiosis.
title_fullStr Herpes simplex virus infection, Acyclovir and IVIG treatment all independently cause gut dysbiosis.
title_full_unstemmed Herpes simplex virus infection, Acyclovir and IVIG treatment all independently cause gut dysbiosis.
title_short Herpes simplex virus infection, Acyclovir and IVIG treatment all independently cause gut dysbiosis.
title_sort herpes simplex virus infection acyclovir and ivig treatment all independently cause gut dysbiosis
url https://doi.org/10.1371/journal.pone.0237189
work_keys_str_mv AT chandranramakrishna herpessimplexvirusinfectionacyclovirandivigtreatmentallindependentlycausegutdysbiosis
AT staceemendonca herpessimplexvirusinfectionacyclovirandivigtreatmentallindependentlycausegutdysbiosis
AT paulmruegger herpessimplexvirusinfectionacyclovirandivigtreatmentallindependentlycausegutdysbiosis
AT janehannahkim herpessimplexvirusinfectionacyclovirandivigtreatmentallindependentlycausegutdysbiosis
AT jamesborneman herpessimplexvirusinfectionacyclovirandivigtreatmentallindependentlycausegutdysbiosis
AT edouardmcantin herpessimplexvirusinfectionacyclovirandivigtreatmentallindependentlycausegutdysbiosis